Propel Bio Management »

Scynexis shares owned by Propel Bio Management

Quarter-by-quarter ownership of Scynexis shares owned by Propel Bio Management from 13F filings

Historical chart of Propel Bio Management investment in Scynexis

Tip: Access up to 7 years of quarterly data

All positions including Scynexis held by Propel Bio Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Scynexis by Propel Bio Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $2.2M 544k 4.07

More positions owned by Propel Bio Management

Plains Gp Holdings Lp-cl Comm (PAGP)
Achieve Life Sciences Comm (ACHV)
Corcept Therapeutics Comm (CORT)
Phathom Pharmaceuticals I Comm (PHAT)
Delcath Systems Comm (DCTH)
Milestone Pharmaceuticals Comm (MIST)
Compass Pathways Adrs (CMPS)
Kyverna Therapeutics Comm (KYTX)
Artiva Biotherapeutics In Comm (ARTV)
Abeona Therapeutics Comm (ABEO)
Aquestive Therapeutics In Comm (AQST)
Palisade Bio Comm (PALI)
Immunic Comm (IMUX)
Inventiva Sa - Comm (IVA)
Sab Biotherapeutics Comm (SABS)

View all positions for Propel Bio Management

Top funds holding Scynexis

Dr. Jeffrey R. Jay, M.D.
Squadron Capital Management
Adage Capital Partners GP
Propel Bio Management
Woodline Partners
Vanguard Capital Management
Avidity Partners Management
Kingdon Capital Management
Millennium Management
Heights Capital Management
DAFNA Capital Management
Empery Asset Management
Acadian Asset Management
Geode Capital Management
Renaissance Technologies

View all funds holding Scynexis